Biotech

Category / Pharmaceuticals & Biotech / Biotech

Angle PLC: Placing to Raise GBP 10.2 Million

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 05/25/16 -- Angle PLCOTCQX: ANPCY ("ANGLE" or "the Company")ANGLE plc (AIM: AGL and OTCQX: ANPCY), the specialist medtech company, is pleased ...

Angle PLC: Cancer Research UK Contract

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 05/25/16 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)OTCQX:ANPCYANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is delighted to announce that it has s ...

Theratechnologies Announces that 82.5% of Patients Achieved the Primary Endpoint in the Phase III Ibalizumab Trial

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/24/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announces that it has been notified by its partner, TaiMed Biologics, Inc., of the preliminary r ...

Salford Lung Study Results Show COPD Patients Treated With Relvar(R) Ellipta(R) Achieve Superior Reduction in Exacerbations Compared to 'Usual Care'

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: Pioneering GSK Study Provides Important New Data on the Effectiveness of Relvar Ellipta (FF/VI) When Used in Everyday Clinical Practice ...

True Nature Signs Letter of Intent to Acquire Third Atlanta Compounder

ATLANTA, GA: Innovation Compounding's Founder Is Slated for Board Role, COO Slot ...

Avid Bioservices Appoints Pete Gagnon as Vice President of Process Sciences

TUSTIN, CA: Leading Innovator in Field of Biologics Purification Brings Unique Manufacturing Experience to Broaden Avid's Capabilities, Including Biosimilar Expertise ...

Medgenics to Present at the UBS Global Healthcare Conference

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 05/20/16 -- (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the annual UBS Global Healthcare Confere ...

Vaxil Board Member Joins Ontario Premier Kathleen Wynne's Business Mission to Israel

TORONTO, ONTARIO and REHOVOT, ISRAEL: TORONTO, ONTARIO and REHOVOT, ISRAEL -- (Marketwired) -- 05/19/16 -- VAXIL BIO LTD. (TSX VENTURE: VXL), an Israeli biotechnology company specializing in cancer immuno-oncology (I/O), reports that one ...

Immunotherapy Journal Review of Anti - CD3 Monoclonal Antibodies Highlights Therapeutic Potential of Tiziana's Foralumab

LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 05/19/16 -- Tiziana Life Sciences plc (AIM: TILS)- Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs t ...

Trillium Therapeutics Announces Presentation on TTI-621 Immune Checkpoint Inhibitor Targeting CD47 at 2016 ASCO Annual Meeting

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/18/16 -- Trillium Therapeutics Inc. (TSX: TR) (NASDAQ: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of can ...

GSK Presents Efficacy Data for Anoro(R) Ellipta(R) in COPD Patients Who Remained Symptomatic on Tiotropium

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/18/16 -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced results from data presented at the American Thoracic S ...

GSK Present New Data From Breo(R) Ellipta(R) SUMMIT Study in Patients With COPD at ATS Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/18/16 -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that GlaxoSmithKline plc (GSK) presented new data at t ...

EAG Inc. Announces Additional Investments to Enhance ABC Laboratories' Biopharmaceutical Characterization Capabilities

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 05/18/16 -- EAG Inc. announced today a major investment in ABC Laboratories' capacity and analytical capabilities to meet the pharmaceutical industry's nee ...

Ceapro Inc. Reports 2016 First Quarter Financial Results and Provides Corporate Update

EDMONTON, ALBERTA: Ceapro Posts Highest Quarterly Revenues Reported in Company's History Expected Commencement of Clinical Program With Avenanthramides as Anti-Inflammatory Compound Before Year End Pilot Clinical S ...

Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 05/17/16 -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders for the 2015 fiscal year. It was chaired by Dawn Svoronos, chair of th ...

Bingo to Biotech: the Pharma-Bio Industry Breathes New Life Into Old Buildings Across the World, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwired) -- 05/17/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The very core of the is ingenuity and innovation. And, those dual philoso ...

Theratechnologies Inc.: Update on Tesamorelin Marketing Authorization Application in Brazil

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/16/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that its commercial partner, Sanofi, along with Theratechnologies, have decided to wit ...

New Data Analyses From Phase 3 ATTAIN Trials Support VIBATIV(R) (Telavancin) as a Treatment for Staphylococcus Aureus HABP/VABP, Including Cases Caused by MRSA

DUBLIN, IRELAND: Presentation at American Thoracic Society 2016 International Conference Suggests Potential Efficacy and Overall Mortality Benefits for Select HABP/VABP Patients With VIBATIV Therapy; Shows No Statisti ...

Cleveland BioLabs Reports First Quarter 2016 Financial Results and Development Progress

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 05/16/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2016.Cleveland BioLabs reported a net loss, ...

Microbix Revenue Grows 7% in Second Quarter

TORONTO, ONTARIO: Company provides corporate updates ...

Seite 39 von 255: 1 « .. 38 39 40 41 42 43 44 45 46 47 .. » 255